Boc-His(Tos)-DCHA contains a histidine side chain bearing a tosyl (Tos) protecting group on the imidazole nitrogen, along with a Boc (tert-butoxycarbonyl) carbamate protecting group on the amino functionality and a free carboxylic acid for controlled reactivity. The molecule is a protected amino acid derivative featuring the imidazole ring substituted to restrict nucleophilicity, and the DCHA moiety indicates the presence of a dicyclohexylamine (DCHA) counterion associated with the carboxylate, which can influence solubility and handling. Boc-His(Tos)-DCHA is used as a stepwise peptide-synthesis building block or intermediate, where orthogonal protection of the histidine side-chain functionality supports chemoselective coupling and minimizes side reactions during assembly and subsequent deprotection.
CAT No: CP01009
CAS No:65057-34-3
Synonyms/Alias:N-α-Boc-N-im-tosyl-L-histidine dicyclohexylamine salt;65057-34-3;Dicyclohexylamine(S)-2-((tert-butoxycarbonyl)amino)-3-(1-tosyl-1H-imidazol-4-yl)propanoate;AC1O5ALA;Boc-His(Toc)-OH.DCHA;15507_ALDRICH;15507_FLUKA;C30H46N4O6S;CTK2F6671;MolPort-003-926-824;EINECS265-328-0;9956AB;AKOS016010084;Boc-His(Tos)-OHdicyclohexylaminesalt;N-(tert-Butoxycarbonyl)-1-(p-tosyl)-L-histidine,compoundwithdicyclohexylamine(1:1);AK115073;AM001829;ST2419224;Boc-His(Tos)-OH(dicyclohexylammonium)salt;FT-0640989;3B3-051402;Nalpha-Boc-N(im)-tosyl-L-histidinedicyclohexylaminesalt;Nalpha-Boc-N(im)-tosyl-L-histidine(dicyclohexylammonium)salt;N-alpha-t-Butyloxycarbonyl-n-Im-t-tosyl-L-histidinedicyclohexylamine;(2S)-2-[(TERT-BUTOXYCARBONYL)AMINO]-3-[1-(4-METHYLBENZENESULFONYL)IMIDAZOL-4-YL]PROPANOICACID;DICHA
Boc-His(Tos)-DCHA is a protected histidine derivative featuring a Boc-protected alpha-amino group and a tosyl-protected imidazole side chain, with DCHA indicating a dicyclohexylamine (DCHA) salt form that modulates handling and crystallinity. The molecule retains histidine's stereogenic alpha-carbon as the D configuration and presents a carboxylate functionality suitable for conversion into peptide-coupling-ready forms. The Boc carbamate and Tosylated imidazole impose orthogonal protection that can be selectively removed or transformed during peptide building, while the salt counterion supports reproducible solid-state behavior for synthetic workflows. The combination of protected amine, protected side-chain nucleophile, and chiral center makes Boc-His(Tos)-DCHA a practical chiral amino acid intermediate for controlled amino acid derivatization and downstream peptide analog construction.
1. Protected Amino Acids
Boc-His(Tos)-DCHA is applied in protected amino acid chemistry where orthogonal deprotection and selective functional group manipulation are required for stepwise synthesis. The Boc carbamate masks the alpha-amino group for peptide coupling compatibility, while the tosyl group suppresses imidazole reactivity during activation and coupling steps. The DCHA salt form can facilitate reproducible weighing, dissolution behavior, and intermediate handling when preparing protected amino acid building blocks for multi-step assembly. Boc-His(Tos)-DCHA can be employed as a chiral intermediate to access histidine-containing derivatives with controlled exposure of the imidazole for later conjugation, cyclization, or metal-binding motif installation.
2. Peptide Synthesis
Boc-His(Tos)-DCHA is used in peptide synthesis workflows targeting histidine incorporation with minimized side reactions from the imidazole. The protected imidazole (Tos) reduces undesired nucleophilic participation during amide bond formation, while the Boc-protected alpha-amino functionality supports standard peptide coupling strategies after deprotection. The stereodefined D configuration at the alpha-carbon enables construction of D-histidine-containing peptides for stereochemical studies and peptidomimetic design. The resulting histidine-bearing peptide products can be further processed by imidazole deprotection and functionalization, enabling controlled generation of peptide scaffolds that retain histidine's coordination and protonation behavior.
3. Peptidomimetics And SAR
Boc-His(Tos)-DCHA is suitable for peptidomimetic and structure-activity relationship studies where histidine side-chain chemistry must be introduced with protection during scaffold assembly. The imidazole's protected state supports incorporation into longer sequences or cyclic constraints without premature side-chain reactions, and subsequent deprotection can enable formation of functional motifs such as metal-binding sites or pH-responsive interaction handles. The chiral D-histidine center provides stereochemical control for SAR campaigns that compare backbone or side-chain stereochemistry effects on binding and conformation. Boc-His(Tos)-DCHA can be used to generate libraries of histidine-modified analogs and intermediate fragments for iterative medicinal chemistry refinement.
4. Bioconjugation Chemistry
Boc-His(Tos)-DCHA can be applied in bioconjugation chemistry to prepare histidine-derived reactive handles for controlled attachment to biomolecules or surfaces. The protected imidazole allows stable storage and transport through multi-step conjugation planning, while orthogonal deprotection can later reveal the imidazole nucleophile for coupling to activated electrophiles or for coordination-driven assembly strategies. The Boc-protected alpha-amino group supports conversion into amino acid-derived linkers that can be integrated into peptide tags, affinity ligands, or spacer units. The DCHA salt form supports practical intermediate handling when manufacturing conjugation reagents at scale, supporting downstream formation of histidine-functional biomolecule conjugates.
5. Process Chemistry Intermediate
Boc-His(Tos)-DCHA is relevant to process chemistry intermediate preparation for manufacturing routes that require robust, isolable protected amino acid forms. The Boc and Tosyl protections provide chemical stability under conditions commonly used for amino acid activation and peptide coupling, supporting reproducible intermediate throughput in fine chemical synthesis. The salt nature of the DCHA form can improve solid handling characteristics and batch consistency, which is advantageous when scaling protected amino acid production and downstream peptide building block preparation. Boc-His(Tos)-DCHA can serve as a chiral input for industrial synthesis of histidine-containing peptides, peptidomimetics, and protected intermediates used across specialty chemical production pipelines.
2. Implications of ligand-receptor binding kinetics on GLP-1R signalling
5. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.